These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30414597)

  • 21. Evolution of respiratory mechanics in preterm babies after surfactant administration in the neonatal period.
    Parmigiani S; Panza C; Bevilacqua G
    Acta Biomed Ateneo Parmense; 1997; 68 Suppl 1():65-73. PubMed ID: 10021719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Observational study to compare the clinical efficacy of the natural surfactants Alveofact and Curosurf in the treatment of respiratory distress syndrome in premature infants.
    Proquitté H; Dushe T; Hammer H; Rüdiger M; Schmalisch G; Wauer RR
    Respir Med; 2007 Jan; 101(1):169-76. PubMed ID: 16698258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RETREATMENT WITH SURFACTANT IN VERY LOW BIRTH WEIGHT PRETERM INFANTS: RISK PREDICTORS AND THEIR INFLUENCE ON NEONATAL OUTCOMES.
    Ferri WAG; Silva ACD; Sacramento EMF; Calixto C; Aragon DC; Caldas JPS
    Rev Paul Pediatr; 2020; 39():e2019360. PubMed ID: 33206840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiorespiratory Physiology following Minimally Invasive Surfactant Therapy in Preterm Infants.
    Sehgal A; Bhatia R; Roberts CT
    Neonatology; 2019; 116(3):278-285. PubMed ID: 31487729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in hemodynamics after rescue surfactant administration.
    Katheria AC; Leone TA
    J Perinatol; 2013 Jul; 33(7):525-8. PubMed ID: 23328925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of Infasurf (calf lung surfactant extract) to Survanta (Beractant) in the treatment and prevention of respiratory distress syndrome.
    Bloom BT; Kattwinkel J; Hall RT; Delmore PM; Egan EA; Trout JR; Malloy MH; Brown DR; Holzman IR; Coghill CH; Carlo WA; Pramanik AK; McCaffree MA; Toubas PL; Laudert S; Gratny LL; Weatherstone KB; Seguin JH; Willett LD; Gutcher GR; Mueller DH; Topper WH
    Pediatrics; 1997 Jul; 100(1):31-8. PubMed ID: 9200357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative efficacy and safety of late surfactant preparations: a retrospective study.
    Lane MD; Kishnani S; Udemadu O; Danquah SE; Treadway RM; Langman A; Balevic S; Jackson WM; Laughon M; Hornik CP; Greenberg RG; Clark RH; Zimmerman KO
    J Perinatol; 2021 Nov; 41(11):2639-2644. PubMed ID: 34285358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lyso-phosphatidylcholine and outcome of preterm babies with respiratory distress syndrome treated with surfactant.
    O'Hare MM; Bingham AM; McMaster C; Halahakoon WL; Corcoran JD; Halliday HL
    Early Hum Dev; 1997 Sep; 49(2):135-41. PubMed ID: 9226120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surfactant without intubation in preterm infants with respiratory distress: first multi-center data.
    Kribs A; Härtel C; Kattner E; Vochem M; Küster H; Möller J; Müller D; Segerer H; Wieg C; Gebauer C; Nikischin W; Wense Av; Herting E; Roth B; Göpel W
    Klin Padiatr; 2010; 222(1):13-7. PubMed ID: 20084586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of surfactant treatment in late preterm infants with respiratory distress syndrome.
    Dani C; Mosca F; Vento G; Tagliabue P; Picone S; Lista G; Fanos V; Pratesi S; Boni L
    J Matern Fetal Neonatal Med; 2018 May; 31(10):1259-1266. PubMed ID: 28367650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surfactant replacement therapy in preterm infants: a European survey.
    van Kaam AH; De Jaegere AP; Borensztajn D; Rimensberger PC;
    Neonatology; 2011; 100(1):71-77. PubMed ID: 21228602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of efficacy between two natural exogenous surfactant preparations in premature infants with respiratory distress syndrome.
    Yalaz M; Arslanoglu S; Akisu M; Atik T; Ergun O; Kultursay N
    Klin Padiatr; 2004; 216(4):230-5. PubMed ID: 15284947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of the cost-effectiveness of surfactant treatment (Curosurf®) in respiratory distress syndrome therapy in preterm infants: early treatment compared to late treatment.
    Dani C; Ravasio R; Fioravanti L; Circelli M
    Ital J Pediatr; 2014 May; 40():40. PubMed ID: 24886906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants.
    Ramanathan R; Rasmussen MR; Gerstmann DR; Finer N; Sekar K;
    Am J Perinatol; 2004 Apr; 21(3):109-19. PubMed ID: 15085492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Poractant alfa versus beractant for respiratory distress syndrome in preterm infants: a retrospective cohort study.
    Paul S; Rao S; Kohan R; McMichael J; French N; Zhang G; Simmer K
    J Paediatr Child Health; 2013 Oct; 49(10):839-44. PubMed ID: 23802801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of surfactant for prevention of respiratory distress syndrome in newborn infants in spontaneous breathing. A randomized multicentre clinical pilot-study.
    Dambeanu JM; Parmigiani S; Marinescu B; Bevilacqua G
    Acta Biomed Ateneo Parmense; 1997; 68 Suppl 1():39-45. PubMed ID: 10021716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Neonatal respiratory distress syndrome treated with a natural surfactant. The Norwegian Curosurf study].
    Saugstad OD; Danielsen K; Grønn M; Holt J; Meberg A; Silberg IE; Okland O
    Tidsskr Nor Laegeforen; 1993 Aug; 113(19):2389-93. PubMed ID: 8378900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Surfactant treatment of newborn infants receiving continuous positive airway pressure treatment].
    Andersen T; Holm HS; Kamper J
    Ugeskr Laeger; 2006 Oct; 168(43):3723-7. PubMed ID: 17069738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Animal-derived surfactants: where are we? The evidence from randomized, controlled clinical trials.
    Ramanathan R
    J Perinatol; 2009 May; 29 Suppl 2():S38-43. PubMed ID: 19399008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early versus late surfactant treatment in preterm infants of 27 to 32 weeks' gestational age: a multicenter controlled clinical trial.
    Gortner L; Wauer RR; Hammer H; Stock GJ; Heitmann F; Reiter HL; Kühl PG; Möller JC; Friedrich HJ; Reiss I; Hentschel R; Jorch G; Hieronimi G; Kuhls E
    Pediatrics; 1998 Nov; 102(5):1153-60. PubMed ID: 9794948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.